Meanwhile, down-regulation of HIF-1α/fatty acid synthase co-axis was shown to combat tumor growth in mammary gland carcinoma by activating PHD-2 (Gautam et al., 2018) (Manral et al., 2016). The gene discussed is EGLN1; the disease is neoplasm.